Tag Archives: developing nations

Will WHO Member States Pony Up for Neglected Diseases?

By Ben Comer | Published: May 21, 2012

Recognizing that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organization (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations. [...]

Posted in Emerging Markets, Global, IP, Legal, Manufacturing, Market Access, R&D, leadership, pricing | Also tagged developing countries, funding, neglected diseases, Neglected Tropical Diseases, Novartis, Paul Herrling, R&D, tropical diseases, WHO, World Health Assembly | Leave a comment

US and Europe At Risk from Substandard Medicines

By Julian Upton | Published: February 25, 2010

Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]

Posted in Biotech, Emerging Markets, Europe, Global, Guest Blog, Regulatory, Safety | Also tagged biosimilars, Brazil, China, counterfeit medicines, Emerging Markets, Europe, Indian, Regulatory, substandard medicines, Turkey, US | Leave a comment